NewEdge Advisors LLC increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 20.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,633 shares of the financial services provider’s stock after buying an additional 1,944 shares during the quarter. NewEdge Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,597,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Future Financial Wealth Managment LLC purchased a new position in shares of iShares Biotechnology ETF during the first quarter valued at approximately $27,000. Bbjs Financial Advisors LLC bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth approximately $31,000. Pacifica Partners Inc. boosted its stake in shares of iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after buying an additional 130 shares during the last quarter. YHB Investment Advisors Inc. bought a new position in shares of iShares Biotechnology ETF in the first quarter valued at approximately $37,000. Finally, Mather Group LLC. bought a new position in shares of iShares Biotechnology ETF in the first quarter valued at approximately $57,000. Institutional investors own 62.45% of the company’s stock.
iShares Biotechnology ETF Trading Up 0.9 %
Shares of iShares Biotechnology ETF stock opened at $143.90 on Friday. The business’s fifty day simple moving average is $145.48 and its 200 day simple moving average is $139.10. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $150.57.
iShares Biotechnology ETF Dividend Announcement
iShares Biotechnology ETF Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
See Also
- Five stocks we like better than iShares Biotechnology ETF
- Do ETFs Pay Dividends? What You Need to Know
- 3 Dividend Growth Stocks Set to Supercharge Your Portfolio
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- Investing In Preferred Stock vs. Common Stock
- MarketBeat Week in Review – 9/30 – 10/4
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.